Mealey's Intellectual Property

  • June 28, 2024

    Federal Circuit Transfers Copyright Row Over Russian Band To 11th Circuit

    WASHINGTON, D.C. — A panel of judges in the Federal Circuit U.S. Court of Appeals found a that record label should not have appealed to that circuit a Florida federal judge’s finding that the label failed to establish personal jurisdiction against a French company for allegedly infringing on copyrights related to a Soviet-era Russian boy band, ordering that the appeal be transferred to the 11th Circuit U.S. Court of Appeals.

  • June 27, 2024

    Federal Circuit: Patent Defendant Not Entitled To Fees After Voluntary Dismissal

    WASHINGTON, D.C. — A company that produces contactless data carrying technology that is used in federal identification documents is not entitled to attorney fees in a patent infringement case because the claims against it were voluntarily dismissed after the plaintiff removed the claims from its amended complaint, a Federal Circuit U.S. Court of Appeals panel found in affirming a judgment from the U.S. Court of Federal Claims on June 26.

  • June 26, 2024

    Music Industry Entities Sue Pair Of AI Companies Over Copying Of Recordings

    NEW YORK — Two companies trained artificial intelligence on decades’ worth of copyrighted sound recordings with “rapid and devastating” effect, various music industry entities claim in a pair of June 25 complaints filed in Massachusetts and New York federal courts, warning that the technology presents both “promise and peril.”

  • June 26, 2024

    7th Circuit: Church, Not Founder’s Grandson, Owns Copyright To Photo Of Founder

    CHICAGO — The son and grandson of the late founder of a Christian organization cannot bring copyright counterclaims about a photo taken of the founder by his son and used in promotional materials, a panel of the Seventh Circuit U.S. Court of Appeals ruled, affirming an Indiana federal judge’s grant of summary judgment in the company’s favor in part because the photo was a “work made for hire.”

  • June 26, 2024

    1st Circuit: Singer Is ‘Featured Artist,’ Entitled To Royalties From Records

    BOSTON — The former lead singer of one of Puerto Rico’s most popular musical acts is a “recording artist . . . featured” on the band’s recordings and not the corporate entity that owns the band or that entity’s owner, a panel of the First Circuit U.S. Court of Appeals ruled, reversing a Puerto Rico federal judge’s decision to deny summary judgment to the singer in a royalty dispute over certain of the band’s recordings.

  • June 25, 2024

    Counterclaims Will Continue In Patent Dispute Over Apple Watch’s Visual Designs

    NEW YORK — Counterclaims of invalidity and noninfringement filed by Apple Inc. in response to patent infringement claims relating to certain visual designs used in the Apple Watch can go forward because Apple has met its pleading requirements, a New York federal judge found in refusing to dismiss the company’s counterclaims.

  • June 25, 2024

    Music Industry’s AI Suit Will Play In California After Transfer

    NASHVILLE, Tenn. — Music publishers sued a California-based artificial intelligence company in Tennessee and must live with the fact that they have not shown that the fact that the company employs a few individuals who chose to work from home in Tennessee satisfies the jurisdiction hurdle, a federal judge in Tennessee said June 24.

  • June 24, 2024

    Panel: Mobile Gambling Patents Abstract And Fail To Contain Inventive Concept

    WASHINGTON, D.C. — A federal judge did not err in dismissing patent infringement claims regarding a series of patents that disclose a method for placing gambling bets from a remote location because the patents are based on an abstract idea and do not contain an inventive concept, a Federal Circuit U.S. Court of Appeals panel found in affirming June 21.

  • June 24, 2024

    High Court Again Extends Response Deadline In Review Of 9th Circuit FCA Reversal

    WASHINGTON, D.C. — The U.S. Supreme Court on June 21 granted a district court qui tam plaintiff’s second request for additional time to respond to pharmaceutical companies’ petition that seeks review of the Ninth Circuit U.S. Court of Appeals’ ruling reversing the district court’s dismissal of a suit accusing the companies of violating the False Claims Act (FCA) by artificially inflating drug prices.

  • June 24, 2024

    5th Circuit: Store Infringed ‘Appliance Liquidation Outlet’ Mark, But No Fees Owed

    NEW ORLEANS — A Fifth Circuit U.S. Court of Appeals panel on June 21 partly reversed a Texas federal judge’s finding in a trademark infringement case, finding that the judge correctly held that a company’s trademark on “Appliance Liquidation Outlet” was infringed but incorrectly held that “Appliance Liquidation” is a valid mark in a dispute between competing stores.

  • June 24, 2024

    High Court To Decide If Lanham Act Allows Disgorgement Of Nonparty Profits

    WASHINGTON, D.C. — The U.S. Supreme Court on June 24 granted a real estate firm’s petition for a writ of certiorari, agreeing to consider whether courts under the Lanham Act “can include an order for the defendant to disgorge the distinct profits of legally separate non-party corporate affiliates” and if the Fourth Circuit U.S. Court of Appeals improperly upheld a $43 million disgorgement award against it.

  • June 21, 2024

    German Companies Claim Microsoft Infringed Patents Through Its AI Infrastructure

    MARSHALL, Texas — Microsoft Corp. infringed three patents by using certain computing systems that allow for artificial intelligence (AI) computer programs to run more efficiently, two German companies allege in a complaint filed in Texas federal court.

  • June 20, 2024

    Claim Construction In Communications Patent Case Was Proper, Federal Circuit Says

    WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel affirmed the Patent Trial and Appeal Board’s (PTAB) claim construction in a dispute over certain methods for controlling transmission power in communication systems and found that the PTAB correctly gave the claim language its plain meaning.

  • June 19, 2024

    Federal Circuit: Injunction Over Trade Secrets Was Not Given Proper Analysis

    WASHINGTON, D.C. — A federal trial court abused its discretion in granting a preliminary injunction to a company that alleges that one of its competitors used trade secrets in developing an insulin patch because the trial court did not properly consider relevant factors such as the applicable statute of limitations and the proper definition of a trade secret, a Federal Circuit U.S. Court of Appeals found in reversing the trial court’s judgment.

  • June 19, 2024

    Microsoft Joins OpenAI’s Call For Consolidation Of Media AI Suits

    NEW YORK — Microsoft Corp. joined in various OpenAI entities’ motion to consolidate a suit brought by eight news organizations challenging outputs from the ChatGPT artificial intelligence and its associated programs with a similar suit filed by The New York Times Co., saying in its joinder brief filed in a federal court in New York that doing so will combine suits that challenge similar technologies.

  • June 19, 2024

    Judge Rules ‘Florida Man’ Not Famous Enough For Dilution In Trademark Dispute

    WEST PALM BEACH, Fla. — A federal judge in Florida granted in part a Florida company and its principal’s motion to dismiss a complaint alleging that the company violated another company’s “FLORIDA MAN” trademark, finding that the mark is not “famous” under federal or Florida law.

  • June 19, 2024

    Federal Circuit: PTAB Used Wrong Construction In Dispute Over Control Devices

    WASHINGTON, D.C. — The Patent Trial and Appeal Board (PTAB) used an erroneous claim construction in rejecting an obviousness challenge filed by television manufacturer Roku Inc., which was sued for allegedly infringing upon a patent for enhanced appliance control methods, the Federal Circuit U.S. Court of Appeals found June 18 in vacating PTAB’s final written decision (FWD).

  • June 18, 2024

    Judgment Requiring Inhaler Patents To Be Delisted Stayed For 30 Days

    TRENTON, N.J. — While stopping short of granting a request to stay his recent order that a drugmaker must delist five patents from the U.S. Food and Drug Administration’s “Orange Book” pending resolution of an appeal, a federal judge in New Jersey has agreed to put the judgment on hold for 30 days.

  • June 18, 2024

    Federal Circuit Judge Stands By Nonobviousness Holding In Drug Dispute

    WILMINGTON, Del. — A Federal Circuit U.S. Court of Appeals judge, visiting in the U.S. District Court for the District of Delaware, said that a recent decision by a panel of his court that reversed and remanded findings that a patented schizophrenia drug is nonobvious won’t prompt him to revisit his own findings in a separate case that confirmed the same formulation as patentable.

  • June 18, 2024

    Counterclaims Tossed In California Patent Row Over Chipmaking Robots

    SAN FRANCISCO — An automation company accused of infringing five reissue patents for chipmaking robots saw its counterclaim for inequitable conduct dismissed, with a federal judge in California rejecting arguments that during patent prosecution an industry standard was purposely withheld from the examiner when the same standard is identified in the specification of the parent patent.

  • June 18, 2024

    Claims Over Hotel’s Use Of Minors’ Photo On Instagram, Website Dismissed

    LOS ANGELES — Citing issues of preemption and shotgun pleadings, a California federal judge dismissed claims of copyright infringement, unfair competition and misappropriation, among others, that were brought against a hotel for its online use of an Instagram picture of two minors that purportedly exceeded any consent granted by the copyright holder.

  • June 18, 2024

    Federal Circuit Denies 2 Petitions For Rehearing In Antibiotic Patent Case

    WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals denied two petitions for rehearing of its decision affirming a Delaware federal judge’s final judgment directing the U.S. Food and Drug Administration to delay approval of generic rifaximin until three patents covering the antibiotic Xifaxan expire.

  • June 17, 2024

    Patent Covering Above-Ground Pool Frame Joint Singled Out For Review

    ALEXANDRIA, Va. — In a June 15 request for post-grant review (PGR), a petitioner says that a patentee’s own above-ground-pool (AGP), sold since 2007, renders various claims of a recently-issued pool frame joint patent obvious, as well as that other claims of the same patent are cancellable as indefinite.

  • June 17, 2024

    4th Circuit: Lanham Act Does Not Preclude Judicial Review In Dispute Over Rum Mark

    RICHMOND, Va. — A panel of judges in the Fourth Circuit U.S. Court of Appeals found that the Lanham Act does not preclude judicial review under the Administrative Procedure Act (APA), remanding to a Virginia federal judge a rum manufacturer’s claim that the U.S. Patent & Trademark Office inappropriately allowed a rival brand to renew a trademark a decade after its expiration.

  • June 17, 2024

    Judge Affirms Jury Verdict, Award Against Creators Of Video Game Cheat

    SEATTLE — Affirming a jury’s finding that five defendants infringed copyrights in the popular Destiny 2 video game series by creating a cheat for it that they sold online, a Washington federal judge also entered a permanent injunction and a monetary judgment of $63,210 in favor of the video game developer, per the jury’s recommendation.

Can't find the article you're looking for? Click here to search the Mealey's Intellectual Property archive.